Brief: WallachBeth Capital Announces Pricing Of ABVC Biopharma $4.22 Million Registered Direct Offering
May 12 (Reuters) - WallachBeth Capital:
* WALLACHBETH CAPITAL ANNOUNCES PRICING OF ABVC BIOPHARMA,
INC.
(NASDAQ: ABVC) $4.22 MILLION REGISTERED DIRECT OFFERING
Source text for Eikon: ID:nPn8CLPl5a
Further company coverage: ABVC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ABVC Biopharma
See all newsBrief: ABVC Biopharma Says Biokey Share Distribution Rescheduled For August 21
NASDAQ RESUMED AT 09:05 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:43 PM
Brief: ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon